These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 9225009

  • 1. CD26/dipeptidyl peptidase IV does not work as an adenosine deaminase-binding protein in rat cells.
    Iwaki-Egawa S, Watanabe Y, Fujimoto Y.
    Cell Immunol; 1997 Jun 15; 178(2):180-6. PubMed ID: 9225009
    [Abstract] [Full Text] [Related]

  • 2. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.
    Dong RP, Kameoka J, Hegen M, Tanaka T, Xu Y, Schlossman SF, Morimoto C.
    J Immunol; 1996 Feb 15; 156(4):1349-55. PubMed ID: 8568233
    [Abstract] [Full Text] [Related]

  • 3. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation.
    Dong RP, Tachibana K, Hegen M, Munakata Y, Cho D, Schlossman SF, Morimoto C.
    J Immunol; 1997 Dec 15; 159(12):6070-6. PubMed ID: 9550406
    [Abstract] [Full Text] [Related]

  • 4. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.
    Hühn J, Olek S, Fleischer B, von Bonin A.
    Cell Immunol; 1999 Feb 25; 192(1):33-40. PubMed ID: 10066344
    [Abstract] [Full Text] [Related]

  • 5. Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26.
    Blanco J, Marié I, Callebaut C, Jacotot E, Krust B, Hovanessian AG.
    Exp Cell Res; 1996 May 25; 225(1):102-11. PubMed ID: 8635502
    [Abstract] [Full Text] [Related]

  • 6. Binding of adenosine deaminase to the lymphocyte surface via CD26.
    De Meester I, Vanham G, Kestens L, Vanhoof G, Bosmans E, Gigase P, Scharpé S.
    Eur J Immunol; 1994 Mar 25; 24(3):566-70. PubMed ID: 7907293
    [Abstract] [Full Text] [Related]

  • 7. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase.
    Sharoyan S, Antonyan A, Mardanyan S, Lupidi G, Cristalli G.
    Acta Biochim Pol; 2006 Mar 25; 53(3):539-46. PubMed ID: 16929383
    [Abstract] [Full Text] [Related]

  • 8. Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding.
    Yu DM, Slaitini L, Gysbers V, Riekhoff AG, Kähne T, Knott HM, De Meester I, Abbott CA, McCaughan GW, Gorrell MD.
    Scand J Immunol; 2011 Feb 25; 73(2):102-11. PubMed ID: 21198750
    [Abstract] [Full Text] [Related]

  • 9. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule.
    Martín M, Huguet J, Centelles JJ, Franco R.
    J Immunol; 1995 Nov 15; 155(10):4630-43. PubMed ID: 7594462
    [Abstract] [Full Text] [Related]

  • 10. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain?
    Iwaki-Egawa S, Watanabe Y, Fujimoto Y.
    Immunobiology; 1995 Nov 15; 194(4-5):429-42. PubMed ID: 8749235
    [Abstract] [Full Text] [Related]

  • 11. Concurrent measurement of adenosine deaminase and dipeptidyl peptidase IV activity in the diagnosis of tuberculous pleural effusion.
    Küpeli E, Karnak D, Elgün S, Argüder E, Kayacan O.
    Diagn Microbiol Infect Dis; 2009 Dec 15; 65(4):365-71. PubMed ID: 19762195
    [Abstract] [Full Text] [Related]

  • 12. Cytofluorographic evidence that thymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny and apoptotic status.
    Ruiz P, Nassiri M, Steele B, Viciana AL.
    Cytometry; 1996 Apr 01; 23(4):322-9. PubMed ID: 8900475
    [Abstract] [Full Text] [Related]

  • 13. Lack of adenosine deaminase activity in cultured murine cytotoxic T lymphocytes.
    Minkowski MD, Castellazzi M, Buttin G.
    J Immunol; 1984 Jul 01; 133(1):52-8. PubMed ID: 6609994
    [Abstract] [Full Text] [Related]

  • 14. Syzygium cumini inhibits adenosine deaminase activity and reduces glucose levels in hyperglycemic patients.
    Bopp A, De Bona KS, Bellé LP, Moresco RN, Moretto MB.
    Fundam Clin Pharmacol; 2009 Aug 01; 23(4):501-7. PubMed ID: 19709327
    [Abstract] [Full Text] [Related]

  • 15. Specific and irreversible cyclopeptide inhibitors of dipeptidyl peptidase IV activity of the T-cell activation antigen CD26.
    Nguyen C, Blanco J, Mazaleyrat JP, Krust B, Callebaut C, Jacotot E, Hovanessian AG, Wakselman M.
    J Med Chem; 1998 Jun 04; 41(12):2100-10. PubMed ID: 9622551
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adenosine deaminase binding to human CD26 is inhibited by HIV-1 envelope glycoprotein gp120 and viral particles.
    Valenzuela A, Blanco J, Callebaut C, Jacotot E, Lluis C, Hovanessian AG, Franco R.
    J Immunol; 1997 Apr 15; 158(8):3721-9. PubMed ID: 9103436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.